Renzenbrink & Partner advise shareholders of Karl Kaps GmbH & Co. KG on sale to Lifco AB

Renzenbrink & Partner advised the shareholders of Karl Kaps GmbH & Co. KG on the sale to listed Swedish industrial group Lifco AB. The transaction concerns the acquisition of Karl Kaps GmbH & Co. KG by Lifco AB. Karl Kaps, founded in 1946 and headquartered in Aßlar near Wetzlar, is a long-established, family-owned German medical-technology company. It develops and manufactures advanced surgical and diagnostic microscopes for specialties including ENT, ophthalmology, microsurgery, endodontics and gynaecology, and produces high-quality optical products such as riflescopes and binoculars for hunting and sports shooting. Its Made in Germany products are distributed worldwide via an established dealer network and are recognised for precision, technical excellence and sustained innovative strength. Lifco AB is an international industrial group that focuses on the long-term development of market-leading niche businesses through a decentralised organisational model. Lifco pursues a growth strategy driven by acquisitions across strategically attractive segments and operates hundreds of portfolio companies globally. The acquisition of Karl Kaps represents a further step in strengthening Lifco’s presence in the medical-technology and optics sectors. Renzenbrink & Partner represented the shareholders of Karl Kaps GmbH & Co. KG with a team composed by: Dr. Ulf Renzenbrink (Corporate/M&A), Dr. Andreas Stoll (Corporate/M&A), Dr. Alexander Haunschild (Corporate/M&A), Marc Philip Priesmeyer (Corporate/M&A), Dr. Nils Rüstmann (Corporate/M&A) and Dr. Jens Wrede (Tax/M&A).

Renzenbrink & Partner advise shareholders of Karl Kaps GmbH & Co. KG on sale to Lifco AB

Read the full story